Fol. Biol. 2005, 51, 188-197
https://doi.org/10.14712/fb2005051060188
Toll-like Receptors. II. Distribution and Pathways Involved in TLR Signalling
References
1. 2002) Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 69, 3155-3162.
< , B., Thieblemont, N., Quesniaux, V. J., Brown, N., Mpagi, J., Miyake, K., Bihl, F., Ryffel, B. (https://doi.org/10.4049/jimmunol.169.6.3155>
2. 2001) Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated prointlammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167, 1609-1616.
< , M. T., Vora, P., Faure, E., Thomas, L. S., Arnold, E. T., Arditi, M. (https://doi.org/10.4049/jimmunol.167.3.1609>
3. 1990) A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9, 1897-1906.
< , S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., Kishimoto, T. (https://doi.org/10.1002/j.1460-2075.1990.tb08316.x>
4. 2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732-738.
< , L., Holt, A. C., Medzhitov, R., Flavell, R. A. (https://doi.org/10.1038/35099560>
5. 2000) Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat. Immunol. 1, 533-540.
< , L., Mira, J. P., Teusch, N., Kline, L., Guha, M., Mackman, N., Godowski, P. J., Ulevitch, R. J., Knaus, U. G. (https://doi.org/10.1038/82797>
6. 2002) Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 23, 509-512.
< , A. A. (https://doi.org/10.1016/S1471-4906(02)02317-7>
7. 2004) Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect. Immun. 72, 788-794.
< , J., Knapp, S., Weijer, S., Leemans, J. C., Pater, J. M., Speelman, P., Florquin, S., van der Poll, T. (https://doi.org/10.1128/IAI.72.2.788-794.2004>
8. 1995) Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373, 531-536.
< , L., Hession, C., Ogata, L., Reilly, C., Marconi, L. A., Olson, D., Tizard, R., Cate, R., Lo, D. (https://doi.org/10.1038/373531a0>
9. 2000) Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2, 346-351.
< , K., Clatworthy, J., Martin, L., Martinon, F., Plumpton, C., Maschera, B., Lewis, A., Ray, K., Tschopp, J., Volpe, F. (https://doi.org/10.1038/35014038>
10. 1999) The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 163, 4453-4461.
< , J., Alexander, J., Craig, L., Bravo, R., Hunter, C. A. (https://doi.org/10.4049/jimmunol.163.8.4453>
11. 2004) Direct bacterial protein PAMPs recognition by human NK cells involves TLRs and triggers {alpha}-defensin production. Blood 104, 1778-1783.
< , A., Jeannin, P., Gauchat, J. F., Blaecke, A., Malissard, M., N'Guyen, T., Thieblemont, N., Delneste, Y. (https://doi.org/10.1182/blood-2003-08-2820>
12. 1999) JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11, 721-731.
< , W. M., Ostertag, D., Li, Z. W., Chang, L., Chen, Y., Hu, Y., Williams, B., Perrault, J., Karin, M. (https://doi.org/10.1016/S1074-7613(00)80146-6>
13. 2003) Human beta-defensins and toll-like receptors in the upper airway. Allergy 58, 748-753.
< , S., de Belder, T., Holtappels, G., Gevaert, P., Verhasselt, B., van Cauwenberge, P., Bachert, C. (https://doi.org/10.1034/j.1398-9995.2003.00180.x>
14. 2004) Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J. Immunol. 172, 880-889.
< , M., Ucker, D. S. (https://doi.org/10.4049/jimmunol.172.2.880>
15. 2002) IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17, 251-263.
< , S., Vaidya, S., O'Connell, R., Dadgostar, H., Dempsey, P., Wu, T., Rao, G., Sun, R., Haberland, M., Modlin, R., Cheng, G. (https://doi.org/10.1016/S1074-7613(02)00390-4>
16. 2003) Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung. Histochem. Cell Biol. 119, 103-108.
< , D., Goldmann, T., Branscheid, D., Clark, R., Dalhoff, K., Zabel, P., Vollmer, E. (https://doi.org/10.1007/s00418-003-0497-4>
17. 2000) Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275, 11058-11063.
< , E., Equils, O., Sieling, P. A., Thomas, L., Zhang, F. X., Kirschning, C. J., Polentarutti, N., Muzio, M., Arditi, M. (https://doi.org/10.1074/jbc.275.15.11058>
18. 2002) Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J. Immunol. 168, 2424-2432.
< , R. N., Cronin, A. O., Lien, E., Anderson, D. J., Ingalls, R. R. (https://doi.org/10.4049/jimmunol.168.5.2424>
19. 2001) Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78-83.
< , K. A., Palsson-McDermott, E. M., Bowie, A. G., Jefferies, C. A., Mansell, A. S., Brady, G., Brint, E., Dunne, A., Gray, P., Harte, M. T., McMurray, D., Smith, D. E., Sims, J. E., Bird, T. A., O'Neill, L. A. (https://doi.org/10.1038/35092578>
20. 2003) LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198, 1043-1055.
< , K. A., Rowe, D. C., Barnes, B. J., Caffrey, D. R., Visintin, A., Latz, E., Monks, B., Pitha, P. M., Golenbock, D. T. (https://doi.org/10.1084/jem.20031023>
21. 2001) Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J. Biol. Chem. 276, 51197-51203.
< , S., Kelly, R. A., Bourcier, T. (https://doi.org/10.1074/jbc.M009160200>
22. 1998) Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187, 147-159.
< , G., Carlson, L., Poljak, L., Shores, E. W., Epstein, S., Leonardi, A., Grinberg, A., Tran, T., Scharton-Kersten, T., Anver, M., Love, P., Brown, K., Siebenlist, U. (https://doi.org/10.1084/jem.187.2.147>
23. 1998) Autocrine/paracrine IFN-alpha-beta mediates the lipopolysaccharide-induced activation of transcription factor Stat1 alpha in mouse macrophages: pivotal role of Stat1 alpha in induction of the inducible nitric oxide synthase gene. J. Immunol. 161, 4803-4810.
< , J. J., Filla, M. B., Fultz, M. J., Vogel, S. N., Russell, S. W., Murphy, W. J. (https://doi.org/10.4049/jimmunol.161.9.4803>
24. 2001) Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167, 1882-1885.
< , A. T., Navas, T. A., Lyons, S., Godowski, P. J., Madara, J. L. (https://doi.org/10.4049/jimmunol.167.4.1882>
25. 1998) NF-kappa B and Re1 proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
< , S., May, M. J., Kopp, E. B. (https://doi.org/10.1146/annurev.immunol.16.1.225>
26. 1997) Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J. Exp. Med. 186, 1535-1546.
< , N. A., Gabriele, L., Doherty, T. M., Klinman, D. M., Tadesse-Heath, L., Contursi, C., Epstein, S. L., Morse, H. C. 3rd (https://doi.org/10.1084/jem.186.9.1535>
27. 2004) Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J. Biol. Chem. 279, 2712-2718.
< , L., Medjane, S., Le-Barillec, K., Balloy, V., Danel, C., Chignard, M., Si-Tahar, M. (https://doi.org/10.1074/jbc.M305790200>
28. 1999) Bacterial peptidoglycan induces CD 14-dependent activation of transcription factors CREB/ATF and AP-1. J. Biol. Chem. 274, 14012-14020.
< , D., Wang, Q., Vinson, C., Dziarski, R. (https://doi.org/10.1074/jbc.274.20.14012>
29. 2003) Toll-like receptors stimulate human neutrophil function. Blood 102, 2660-2669.
< , F., Means, T. K., Luster, A. D. (https://doi.org/10.1182/blood-2003-04-1078>
30. 2004) The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signalling and viral infection. J. Exp. Med. 199, 1641-1650.
< , H., Takeuchi, O., Sato, S., Yamamoto, M., Kaisho, T., Sanjo, H., Kawai, T., Hoshino, K., Takeda, K., Akira, S. (https://doi.org/10.1084/jem.20040520>
31. 2003) Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J. Immunol. 171, 6820-6826.
< , C. J., Wu, Q., Porter, E. M., Zhang, Y. J., Weismuller, K. H., Godowski, P. J., Ganz, T., Randell, S. H., Modlin, R. L. (https://doi.org/10.4049/jimmunol.171.12.6820>
32. 2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424, 743-748.
< , K., Du, X., Georgel, P., Janssen, E., Tabeta, K., Kim, S. O., Goode, J., Lin, P., Mann, N., Mudd, S., Crozat, K., Sovath, S., Han, J., Beutler, B. (https://doi.org/10.1038/nature01889>
33. 2005) IRF-7 is the master regulator of type I interferon-dependent immune responses. Nature 434, 772-777.
< K, Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Ohba, Y., Takaoka, A., Yoshida, N., Taniguchi, T. (https://doi.org/10.1038/nature03464>
34. 2001) TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2, 835-841.
< , T., Barton, G. M., Medzhitov, R. (https://doi.org/10.1038/ni0901-835>
35. 2002) Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531-4537.
< , V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., Endres, S., Hartmann, G. (https://doi.org/10.4049/jimmunol.168.9.4531>
36. 2002) Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. Int. Immunol. 14, 1225-1231.
< , K., Kaisho, T., Iwabe, T., Takeuchi, O., Akira, S. (https://doi.org/10.1093/intimm/dxf089>
37. 2002) Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 195, 1507-1512.
< , T., Amakawa, R., Kaisho, T., Hemmi, H., Tajima, K., Uehira, K., Ozaki, Y., Tomizawa, H., Akira, S., Fukuhara, S. (https://doi.org/10.1084/jem.20020207>
38. 2001) Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6, 375-388.
< , T., Yoneyama, M., Yamaguchi, K., Suhara, W., Mori, W., Shiota, K., Okabe, Y., Namiki, H., Fujita, T. (https://doi.org/10.1046/j.1365-2443.2001.00426.x>
39. 2001) Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31, 3388-3393.
< , D., Napolitani, G., Colonna, M., Sallusto, F., Lanzavecchia, A. (https://doi.org/10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q>
40. 2004) Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Proc. Natl. Acad. Sci. USA 101, 3533-3538.
< , Z., Mak, T. W., Sen, G., Li, X. (https://doi.org/10.1073/pnas.0308496101>
41. 2001) Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 166, 5688-5694.
< , T., Takeuchi, O., Kawai, T., Hoshino, K., Akira, S. (https://doi.org/10.4049/jimmunol.166.9.5688>
42. 1994) Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263, 1612-1615.
< , R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J. (https://doi.org/10.1126/science.7510419>
43. 1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol. Chem. 270, 16483-16486.
< , M. (https://doi.org/10.1074/jbc.270.28.16483>
44. 2005) Pathogen recognition with Toll like receptors. Curr. Opin. Immunol. 17, 338-344.
< , T., Akira, S. (https://doi.org/10.1016/j.coi.2005.02.007>
45. 1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122.
< , T., Adachi, O., Ogawa, T., Takeda, K., Akira, S. (https://doi.org/10.1016/S1074-7613(00)80086-2>
46. 2001) Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167, 5887-5894.
< , T., Takeuchi, O., Fujita, T., Inoue, J., Muhlradt, P. F., Sato, S., Hoshino, K., Akira, S. (https://doi.org/10.4049/jimmunol.167.10.5887>
47. 1994) Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264, 1921-1924.
< , T., Nakayama, K., Penninger, J., Kitagawa, M., Harada, H., Matsuyama, T., Tanaka, N., Kamijo, R., Vilcek, J., Mak, T. W. (https://doi.org/10.1126/science.8009222>
48. 1998) Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation. EMBO J. 17, 3660-3668.
< , P., Stoiber, D., Novy, M., Decker, T. (https://doi.org/10.1093/emboj/17.13.3660>
49. 1991) Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J. Exp. Med. 174, 1517-1526.
< , N., Brand, K., Edgington, T. S. (https://doi.org/10.1084/jem.174.6.1517>
50. 1998) MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell. 2, 253-258.
< , R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C., Ghosh, S., Janeway, C. A. J. (https://doi.org/10.1016/S1097-2765(00)80136-7>
51. 2005) TLR signalling and activation of IRFs: revisiting old friends from the NF-KB pathway. Trends Immunol. 26, 469-476.
< , P. N. (https://doi.org/10.1016/j.it.2005.06.009>
52. 1997) IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278, 1612-1615.
< , M., Ni, J., Feng, P., Dixit, V. M. (https://doi.org/10.1126/science.278.5343.1612>
53. 1998) The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187, 2097-2101.
< , M., Natoli, G., Saccani, S., Levrero, M., Mantovani, A. (https://doi.org/10.1084/jem.187.12.2097>
54. 2000) Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164, 5998-6004.
< , M., Bosisio, D., Polentarutti, N., D'amico, G., Stoppacciaro, A., Mancinelli, R., van't Veer, C., Penton-Rol, G., Ruco, L. P., Allavena, P., Mantovani, A. (https://doi.org/10.4049/jimmunol.164.11.5998>
55. 2003) Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J. Immunol. 171, 3977-3982.
< , H., Okugawa, S., Ota, Y., Yamaguchi, M., Tomizawa, H., Matsushima, K., Ohta, K., Yamamoto, K., Hirai, K. (https://doi.org/10.4049/jimmunol.171.8.3977>
56. 2005) Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6, 769-776.
< G., Rinaldi, A., Bertoni, F., Sallusto, F., Lanzavecchia, A. (https://doi.org/10.1038/ni1223>
57. 2003a) TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4, 161-167.
< , H., Matsumoto, M., Funami, K., Akazawa, T., Seya, T. (https://doi.org/10.1038/ni886>
58. 2003b) TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J. Biol. Chem. 278, 49751-49762.
< , H., Sasai, M., Shida, K., Fujita, T., Matsumoto, M., Seya, T. (https://doi.org/10.1074/jbc.M305820200>
59. 2002) Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 16, 257-270.
< , F., Arron, J., Zheng, Y., Choi, Y., Beg, A. A. (https://doi.org/10.1016/S1074-7613(02)00272-8>
60. 2003) Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int. Immunol. 15, 721-730.
< , A., Bodai, L., Rethi, B., Kenderessy-Szabo, A., Koreck, A., Szell, M., Beer, Z., Bata-Csorgoo, Z., Magocsi, M., Rajnavolgyi, E., Dobozy, A., Kemeny, L. (https://doi.org/10.1093/intimm/dxg068>
61. 2002) Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J. Immunol. 168, 4701-4710.
< , I., Jones, E. C., Usher, L. R., Whyte, M. K., Dower, S. K. (https://doi.org/10.4049/jimmunol.168.9.4701>
62. 2002) The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 295, 1892-1895.
Andre, A., Blackwell, N. M., Hall, L. R., Hoerauf, A., Brattig, N. W., Volkmann, L., Taylor, M. J., Ford, L., Hise, A. G., Lass, J. H., Diaconu, E., Pearlman, E. (
63. 2003) Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem. Biophys. Res. Commun. 306, 860-866.
< , S., Negishi, H., Asagiri, M., Nakajima, C., Mizutani, T., Takaoka, A., Honda, K., Taniguchi, T. (https://doi.org/10.1016/S0006-291X(03)01049-0>
64. 2005) Toll-like receptors. I. Structure, function and their ligands. Folia Biol. (Praha) 51, 148-156.
, F., Buc M. (
65. 2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13, 539-548.
< , M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S., Tanaka, N., Taniguchi, T. (https://doi.org/10.1016/S1074-7613(00)00053-4>
66. 1997) Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J. Exp. Med 186, 1523-1534.
< , T., Contursi, C., Masumi, A., Sher, A., Ozato, K. (https://doi.org/10.1084/jem.186.9.1523>
67. 2005) TLR3 in antiviral immunity: key player or bystander? Trends Immunol. 26, 462-468.
< , M., Bowie A. G. (https://doi.org/10.1016/j.it.2005.07.002>
68. 1995) Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80, 321-330.
< , W. C., Liou, H. C., Tuomanen, E. I., Baltimore, D. (https://doi.org/10.1016/0092-8674(95)90415-8>
69. 2004) Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils. J. Immunol. 172, 5727-5733.
< , D., Asehnoune, K., Park, J. S., Kim, J. Y., He, Q., Richter, D., Kuhn, K., Mitra, S., Abraham, E. (https://doi.org/10.4049/jimmunol.172.9.5727>
70. 2000) STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 11, 199-207.
< , K., Akira, S. (https://doi.org/10.1016/S1359-6101(00)00005-8>
71. 1997) Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6, 673-679.
< , S., Sato, T., Ogasawara, K., Fukuda, T., Sato, M., Hida, S., Suzuki, G., Mitsuyama, M., Shin, E. H., Kojima, S., Taniguchi, T., Asano, Y. (https://doi.org/10.1016/S1074-7613(00)80443-4>
72. 1995) Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80, 353-361.
< , T., Akira, S., Yoshida, K., Umemoto, M., Yoneda, Y., Shirafuji, N., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T. (https://doi.org/10.1016/0092-8674(95)90418-2>
73. 2001) IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655.
< , T., Ogasawara, K., Takaoka, A., Tanaka, N. (https://doi.org/10.1146/annurev.immunol.19.1.623>
74. 2002) The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14, 111-116.
< , T., Takaoka, A. (https://doi.org/10.1016/S0952-7915(01)00305-3>
75. 2004) The low molecular weight GTPase RhoA and atypical protein kinase Czeta are required for TLR2-mediated gene transcription. J. Immunol. 173, 507-514.
< , N., Lombardo, E., Eddleston, J., Knaus, U. G. (https://doi.org/10.4049/jimmunol.173.1.507>
76. 2002) TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3, 392-398.
< , V., Jones, B. W., Perera, P. Y., Thomas, K., Cody, M. J., Zhang, S., Williams, B. R., Major, J., Hamilton, T. A., Fenton, M. J., Vogel, S. N. (https://doi.org/10.1038/ni774>
77. 1993) Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 364, 544-547.
< , C., Caelles, C., van der Geer, P., Hunter, T., Karin, M., Chojkier, M. (https://doi.org/10.1038/364544a0>
78. 2004) Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J. Immunol. 172, 6820-6827.
< , H., Tamura, T., Kong, H. J., Nishiyama, A., Ishii, K. J., Klinman, D. M., Ozato, K. (https://doi.org/10.4049/jimmunol.172.11.6820>
79. 1996) A novel STAT-like factor mediates lipopolysaccharide, interleukin 1 (IL-1), and IL-6 signaling and recognizes a gamma interferon activation site-like element in the IL1B gene. Mol. Cell. Biol. 16, 2183-2194.
< , J., Waterman, W. R., Koyama, Y., Webb, A. C., Auron, P. E. (https://doi.org/10.1128/MCB.16.5.2183>
80. 2002) Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J. Immunol. 168, 5811-5816.
< , S., Matsumoto, M., Takeda, K., Akira, S. (https://doi.org/10.4049/jimmunol.168.11.5811>
81. 2001) Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166, 249-255.
< , A., Mazzoni, A., Spitzer, J. H., Wyllie, D. H., Dower, S. K., Segal, D. M. (https://doi.org/10.4049/jimmunol.166.1.249>
82. 2002) Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J. Immunol. 168, 810-815.
< , X., Moser, C., Louboutin, J. P., Lysenko, E. S., Weiner, D. J., Weiser, J. N., Wilson, J. M. (https://doi.org/10.4049/jimmunol.168.2.810>
83. 2003) Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa. J. Biol. Chem. 278, 50923-50931.
< , C., Miggin, S. M., Jefferies, C. A., O'Neill, L. A. (https://doi.org/10.1074/jbc.M308135200>
84. 2002) In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J. Immunol. 168, 1286-1293.
< , T. G., Buurman, W. A., van Schadewijk, A., de Vries, B., Daemen, M. A., Hiemstra, P. S., van't Veer, C. (https://doi.org/10.4049/jimmunol.168.3.1286>
85. 2002) Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420, 324-329.
< , M., Sato, S., Hemmi, H., Sanjo, H., Uematsu, S., Kaisho, T., Hoshino, K., Takeuchi, O., Kobayashi, M., Fujita, T., Takeda, K., Akira, S. (https://doi.org/10.1038/nature01182>
86. 2003a) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643.
< , M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., Akira, S. (https://doi.org/10.1126/science.1087262>
87. 2003b) TRAM is specifically involved in the Toll-like receptor 4mediated MyD88-independent signaling pathway. Nat. Immunol. 4, 1144-1150.
< , M., Sato, S., Hemmi, H., Uematsu, S., Hoshino, K., Kaisho, T., Takeuchi, O., Takeda, K., Akira, S. (https://doi.org/10.1038/ni986>
88. 2002) Negative regulation of toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 277, 7059-7065.
< , G., Ghosh, S. (https://doi.org/10.1074/jbc.M109537200>